Our Advisory Board of domain experts offer active guidance to help build your business. Cleanint’s Advisory Board provides Cleanint and our partner companies with real-world operational insight and guidance on strategic direction. Our Advisory Board members have a broad range of highly specialized knowledge and strategic, operational expertise in our respective focus areas. The Advisory Board augments our internal resources to achieve Cleanint’s vision of being the preferred catalyst for creating great products.
Professor Dasta received his B.Sc. in Pharmacy in 1974 from West Virginia University School of Pharmacy and M.Sc. and residency in Hospital Pharmacy from The Ohio State University (OSU) in 1976. He began his academic career in 1976 at OSU and developed one of the first practice sites and post-doctoral training programs in critical care pharmacy. He has trained eleven residents and nine fellows who are prominent practitioners, researchers, and leaders in the profession and the pharmaceutical industry.
Professor Dasta was a member of the Society of Critical Care Medicine (SCCM) council, the governing body of SCCM, from 2007-2010. He is a fellow of the American College of Clinical Pharmacy and the American College of Critical Care Medicine. SCCM honored him by creating the Joseph F. Dasta Critical Care Pharmacy Outcomes Research Grant in 2000. Professor Dasta received the 2010 SCCM Distinguished Investigator Award and was the first pharmacist to receive this honor. Professor Dasta was the recipient of the American College of Clinical Pharmacy Education Award in 2002 and the 2010 recipient of the Sustained Contributions to the Literature Award by American Society of Health-System Pharmacists. He serves on the editorial board of Critical Care Medicine and Annals of Pharmacotherapy. Professor Dasta has over 250 peer-reviewed publications, abstracts, brief communications, and book chapters on topics including sedation, analgesia, acute hypertension, hyponatremia, sepsis, acute kidney insufficiency, acute heart failure, and pharmacoeconomics and medication safety of acute care pharmaceuticals. He has also given over 250 lectures on various topics related to critical care and health outcomes.
Dr Ekokobe Fonkem is currently an assistant professor of Medicine, Neurology and Neurosurgery at Texas A & M University Health Science Center College of Medicine and Director of the Brain Tumor Center at Baylor Scott & White Health Care. He completed his undergraduate degree in Biochemistry at the University of Wisconsin- Madison in 2002. He received his medical degree at the Ohio University Heritage College of Osteopathic Medicine in 2007 and went on to complete internship and neurology residency training at the Ohio State University Medical Center in Columbus, OH, followed by Neuro-Oncology Fellowship at Harvard University Beth Israel Deaconess Medical Center in Boston, MA. He has authored and co-authored numerous articles on brain tumors and neurological complications associated with brain tumors. He maintained members with the American Academy of Neurology, Society of Clinical Oncology and Society of Neuro-Oncology. In addition, Dr Fonkem is the Chair and founder of the Fuankem Lekeanyi Memorial Medical Clinic (FLMMC), an organization that was founded to deliver medical care and to empower rural citizens in Cameroon, West Africa.
Mr. Guilloteau is also Director of TMIT, a non-profit medical research organization dedicated to driving adoption of high-impact clinical solutions in patient safety and healthcare performance improvement. He leads all operations serving TMIT in Austin, Texas, and coordinates activities related to TMITs research and scholarship programs. Most recently, he has led the Greenlight Program, a national effort focused on building business cases and clinico-economic models to “green-light” quality and patient safety investments. Over the last three years, Greenlight has targeted healthcare-acquired infections, and now focuses on over-use, misuse, and underuse of imaging studies using the 5 Rights of Imaging™ as a framework. He also leads the team involved in the building and maintenance of SpeakerLink™, a website where healthcare organizations can find and engage patient advocates focused on improving caring in their communities. He has been involved in the Leapfrog National Quality Forum Safe Practice Leap and TMIT High Performer Program, which produces a yearly updated survey, with relative weighting framework and ranking system, to measure the progress of all hospitals toward performance improvement objectives focused on patient safety issues.In addition to his expertise in engineering and product development, he speaks three languages fluently. And received a mechanical engineering degree from the University of Texas at Austin, and subsequently pursued a fellowship in Biomedical Engineering with a minor in product development.
Bob Harding DO FACEP Board Certified Emergency Physician Medical Director of the Seton Highland Lakes Emergency Department. Dr. Harding graduated from Lake Erie College of Osteopathic Medicine and then did his residency at the Lehigh Valley Hospital Emergency Medicine Residency in Bethlehem, Pennsylvania where he served as chief resident. He has special interests in rural emergency medicine and has been instrumental in the development of protocols for stroke, heart attack patients, and trauma patients in the greater Austin area through his involvement with the Capitol Area Trauma Regional Advisory Council. He also has interests in patient safety and in decreasing hospital acquired infections. He has done extensive literature reviews on the transmission on harmful bacteria and viruses to patients from stethoscopes. Dr. Bob uses the Cleanstethoscope on every Emergency Department Shift to decrease the chances of transmitting bacteria and viruses between his patients.
Russ received his B.S. in Microbiology in 1984 from Texas A&M University, and his Master of Public Health from The University of Texas School of Public Health in 1999. The theme of his 30 year career has been the protection and promotion of the public’s health. He has worked in a variety of subject areas including environmental sanitation, microbiology , health care facility licensing and regulation, industrial hygiene, program quality assurance and most recently communicable disease epidemiology.
He is particularly interested in how human behavior, whether it is personal or by organization, involving environmental factors causes or prevents adverse events such as “accidents”, infections, etcetera. Russ has been part of several public health investigations including transmission of airborne disease in congregate settings, health care worker infection, foodborne outbreaks, community acquired MRSA, disaster mortality, as well as novel influenza infections. In 2009 he was part of the national team that detected and investigated the first cases of the novel H1N1 influenza virus.
Dr. Benjamin Tanner holds a B.S. in Molecular Biology and a Ph.D. in Microbiology and Immunology from the University of Arizona, where he studied environmentally mediated disease transmission and assessed infection risks for farm workers. Dr. Tanner is the founder and principal of Antimicrobial Test Laboratories, a microbiology laboratory that specializes in testing and development of disinfectant chemicals and other antimicrobial technologies. Recently, he founded Cosmetic Test Labs, a contract research facility focused on ensuring the safety and stability of cosmetic and other personal care products.
Rodney E. Rohde, Ph.D., M.S., SV, SM, MB (ASCP)CM received his Bachelor of Science (microbiology) and Masters (Biology, emphasis in virology) degrees from Southwest Texas State University (now Texas State University). Dr. Rohde received his Ph.D. in Education in 2010 (Adult Professional Community Education) with a focus on Methicillin Resistant Staphylococcus aureus (MRSA) from Texas State.Dr. Rohde is an associate professor in the College of Health Professions, Clinical Laboratory Science program at Texas State University. In June of 2011, he was appointed as Associate Dean of Research for his college. He is also a clinical assistant professor (joint appointment, non-paid) at Texas Tech University Health Sciences Center, School of Allied Health Sciences, Department of Laboratory Sciences & Primary Care, Clinical Laboratory Science Program. Additionally, Dr. Rohde continues to enjoy being an adjunct associate professor of biology in the nursing program for Austin Community College. He holds certifications as a Specialist in Virology, Specialist in Microbiology, and Molecular Biologist from the American Society for Clinical Pathology.
Rodney spent a decade as a public health microbiologist and molecular epidemiologist with the Texas Department of State Health Services (DSHS) Bureau of Laboratories and Zoonosis Control Division prior to his academic career. While there, Dr. Rohde helped establish the DSHS laboratory as an internationally recognized regional reference laboratory for rabies typing. He also participated in the internationally successful Oral Rabies Vaccination Program which helped eliminate canine rabies from parts of Texas. Rodney received the prestigious J.V. Irons Award for Scientific Excellence from the DSHS Bureau of Laboratories for his efforts in rabies control and prevention.
His research interests are very diverse but focus on adult education and public health microbiology, specifically with respect to rabies virology, oral rabies wildlife vaccination, antibiotic resistant bacteria, and molecular diagnostics/biotechnology. Dr. Rohde has published over 25 research articles and abstracts and presented at over 100 international, national, and state conferences. He has received a variety of grant support for his research. He was awarded the 2007 ASCLS Scientific Research Award for his work with MRSA and the CDC/ATSDR Charles C. Shepard Scientific Award nominee (Assessment Epidemiology category for 2006 publication “Bat-associated Rabies Virus in Skunks”). Dr. Rohde has been the College of Health Professions Presidential Award for Excellence in Scholarly/Creative Activities nominee since 2003.
Dr. Rohde also serves as an Associate Editor for BMC Research journal and as a reviewer for the Emerging Infectious Diseases and International Journal of Molecular Sciences journal. He has been an invited reviewer for numerous clinical microbiology and molecular diagnostic textbooks. Dr. Rohde is considered a subject matter expert in rabies and MRSA, as well as other public health and clinical laboratory topics. Recently, Dr. Rohde has been invited to serve on the Healthcare Environmental Disinfection Advisory Board by the MedErgy Health Group. This group will be focused on the impact of the healthcare environment on Health Acquired Infections (HAIs), including a scientific discussion of how the hospital environment contributes to HAIs, including common infectious agents, how they are spread, and environmental contributors to morbidity and mortality. The Advisory Board is a broad multidisciplinary group focusing on understanding gaps in current evidence, policy, and practice, and discussing how to encourage change in beliefs and behaviors relative to each of these aspects, to ultimately reduce HAIs and improve patient outcomes.
For more specific information about his projects, click here
Rodney enjoys teaching and mentoring students towards productive and exciting careers in clinical laboratories. He also enjoys incorporating research into his student’s and colleagues’ educational experience and challenging them to strive for lifelong learning.